Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion type Assertion NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_head.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion description "[Consistent with this, we show that ATAD2 expression is high in several human tumors and that the expression levels correlate with clinical outcome of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_provenance.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion evidence source_evidence_literature NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_provenance.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion SIO_000772 19843847 NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_provenance.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion wasDerivedFrom befree-20140225 NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_provenance.
- NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_assertion wasGeneratedBy ECO_0000203 NP832654.RAHtivPFOw4Csgi1xH3k1iY9j0bYnyjs-HwYysKTjHs-s130_provenance.